James von Moltke
Analyst · Stuart Graham with Autonomous Research. Please go ahead
Thank you John. Good morning and thank you all for listening today. Let me review our results starting with the group financial summary on Page 3. The reported 12% year-over-year decline in revenues was affected by number of significant one-off items and non-operational charges as well as the impact of asset and business sales. Notwithstanding this, 2017 clearly was a challenging year particularly for the corporate and investment bank which faced a weak revenue environment and for the private and commercial bank that continued to confront headwinds from low interest rates while simultaneously making investments in the business. And while cost remains a challenge, we did make some progress last year, that I will address shortly. And if not for the write-down of our DTA, due to US tax reform we would have reported positive full year net income rather than a loss. Our pre-tax profits also improved with €1.3 billion of reported EBIT following pre-tax losses in each of 2015 and 2016. And our reported EBIT included an additional €1.3 billion of non-operating items like DVA, restructuring, litigation and impairment. Demonstrating the operational profitability in 2017 was not fully represented in our reported results. That said, we're certainly far away from acceptable levels of sustained profitability and returns and have much work to do, to get there. Finally we continued to manage our credit exposure well in 2017 with provisions for credit losses declining nearly €1 billion. Page 4, highlights the impact on our reported revenues of major non-operational items like DVA, the impact of movements in owned credit spreads and that of disposals that we made as part of our strategy. These adjustments result in a 5% year-over-year decline in revenues. And while declines in our core businesses are never welcomed, it shows that our performance was better than our reported results indicate. Let me turn to noninterest expenses on Page 5. Adjusted for FX, fourth quarter noninterest expenses declined 19% or €1.7 billion to €6.9 billion. The decline was primarily driven by €1.3 billion decline in litigation expense year-over-year and the absence of an impairment related to the sale of Abbey Life at the end of 2016. These items more than offset the approximately €400 million increase in restructuring and severance and €350 million increase in adjusted cost in the fourth quarter that I'll detail on the next page. For full year 2017 noninterest expenses of €24.6 billion fell €4.1 billion or 14% primarily reflecting declines in net litigation expense, the absence of major impairments and Abbey Life related policyholder benefits and claims and nearly €500 million decline in adjusted costs. Turning to Page 6, fourth quarter adjusted costs were €6.3 billion, an increase of 6% year-on-year on an FX adjusted basis. While we achieved year-over-year reductions in virtually every component of adjusted costs particularly in professional services fees and occupancy this was more than offset by €600 million increase in compensation expense, that increase in compensation primarily reflected the impact of paying variable compensation for 2017 after not doing so in 2016 as well as from adjusting deferral terms to better match competitor practice and improve the flexibility of our expense base. On a full year basis, adjusted costs declined 2% or approximately €500 million as the increase in compensation expense was offset by declines in other expense items as our restructuring efforts continue to bear fruit. While we made demonstrable progress in a challenging 2017, our fourth quarter expense performance was unsatisfactory and a reminder that it is a management team we have to redouble our efforts to address structural costs and improve the expense culture at Deutsche Bank. Turning to Page 7, we highlight our CET 1 and RWA trends. We reported a fully loaded CET ratio of 14% at year end and 148% on a phase-in basis. The slight increase in both ratios from the third quarter reflected lower RWA that more than offset a decline in CET capital. CET declined to €48.4 billion in the fourth quarter. There were a number of complicated drivers of the CET 1 ratio this quarter that requires some explanation. First; of the reported €2.2 billion loss in the fourth quarter €1.4 billion reflected the write-down of DTA of which a substantial portion was already deducted from our CET 1 capital. Additionally because of ECB accrual policies in the calculation of our regulatory capital previously we could not include €1.7 billion of interim profit from the first three quarters of 2017 in our CET 1 capital. Given the reported full year loss for 2017 this quarter we were able to reverse the accrual of those unrecognized profits which resulted in €1.7 billion addition to CET 1 in the fourth quarter. RWA declined €11 billion to €344 billion as business related RWA growth and CIB of approximately €4 billion was offset by declines in operational risk and market risk. Now let me add a few comments on the CET 1 outlook. Our guidance that we will manage the bank towards the CET 1 ratio comfortably above 13% remains. However there are number of items that will have impacted our CET 1 ratio on January 1, 2018. First the impact of IFRS 9 which is detailed in a slide in the appendix will be approximately 8 basis points on our CET 1 ratio in the first quarter. Additionally, new ECB guidance on the capital treatment of revocable payment commitments to the single resolution fund and deposit guarantee scheme. We estimate we'll reduce our CET 1 by approximately 10 basis points. So our reported 14% fourth quarter CET 1 ratio essentially dropped to approximately 13.8% on the first day of 2018. A further 10 basis point impact will arise from the payment of AT1 group bonds for which no accrual was reflected in the year end 2017 CET 1 because of the reported full year loss. We're also carefully assessing the impact from some ongoing regulatory developments. For example, around the treatment of guaranteed funds which could result in a further reduction to our CET 1 ratio in the first half by as much as an estimated 40 basis points. On the plus side of the ledger, we expect our CET 1 to benefit from the expected partial floatation of our asset management business. Lastly, let me clarify the fact that no common dividend accrual was included in the year-end 2017 CET 1 capital ratio. As a mechanical consequence of having reported to full year loss. As a management board, we've not made a determination regarding a common dividend recommendation in respect to 2017. Fully loaded leverage ratio on Page 8 was 3.8% at year end. Leverage exposure decreased in the quarter by €25 billion. €15 billion on an FX adjusted basis as cash and business growth in CIB were more than offset by declines in pending settlements. I would note that if we excluded Central Bank cash from our leverage calculation as UK appears to and if we were to account for pending settlements under IFRS settlement date accounting our fully loaded leverage ratio would be approximately 80 basis points higher. Let me now turn to the segment results starting with the corporate investment bank on Page 10. CIB reported full year EBIT of just under €900 million down by nearly half versus the prior as the decrease in revenues was only partially offset by lower noninterest expense and lower credit provisions. 2017 CIB revenues of €14.2 billion fell 15% or 13% if you exclude the impact of DVA. This performance principally reflected higher funding costs, low volumes and low volatility in the trading businesses throughout the year. The lag effect of client engagement with us after the challenges we've faced in May, 2016 as a result of the leak of the potential settlement with the US Department of Justice and perimeter adjustments in GTB. Noninterest expenses declined by 8% or €1.1 billion to €13.1 billion primarily driven by €800 million decline in cost associated with litigation and restructuring. And the absence of €300 million goodwill impairment. Adjusted cost in 2017 of €12.9 billion were unchanged as higher compensation expense from the catch up of paying variable compensation for 2017 offset declines in non-compensation costs. For the fourth quarter, CIB reported an EBIT loss of €733 million. The loss resulted from quarterly revenues declining 16% to €2.7 billion and a 2% increase in noninterest expenses again largely driven by higher compensation expense. While this was a difficult year, as the industry faced a challenging revenue environment. We are disappointed with our performance. The fourth quarter was particularly challenging as progress in reducing costs was offset by needed increases to compensation to invest in our franchise after having severely reduced variable compensation in respect of 2016. Credit risk continues to be a good story in CIB, with provisions declining 98% in the quarter and 74% for 2017. In an environment that was broadly stable albeit with some high profile single name credit events that did not impact us. RWA of €232 billion declined 3% from the prior year period as the impact of FX and ongoing de-risking offset increases in Op risk and the inclusion of legacy NCOU assets transferred into CIB at the start of 2017. Let me now turn to the specific CIB business segments, starting with global banking, transaction banking and origination advisory on Page 11. GTB reported fourth quarter revenues of €953 million, a 12% year-over-year decline. As we've noted in the past couple of quarters. There have been a consistent set of factors that have contributed to the GTB revenue declines including the impact of FX and higher group funding costs, persistent margin pressure in trade and strategic client and country perimeter reductions. While GTB's results in the last few quarters have been weaker than expected and we anticipate the current trends to also affect the first quarter's results. Our expectations are for GTB's performance to improve in the second quarter as we will have lapped the impact of a number of the negative headwinds like client and perimeter reductions and should see the benefit of mandates we have won begin to produce revenues particularly in the second half of 2017. Origination and advisory revenues declined 3% to €537 million, but increased 13% from the third quarter 2017. The sequential revenue trend underscores the view we expressed last quarter that our O&A franchise is benefiting from client reengagement with us, following the pressure we experienced in May 2016. Debt origination revenues increased by 14% to €338 million in the fourth quarter and by 18% relative to the third quarter driven by our performing well in investment grade and high yield, both of which saw active markets in the quarter. However equity origination data [ph] revenues fell by €63 million in the fourth quarter [indiscernible] by half €63 million in the fourth quarter, despite a robust issuance calendar that was concentrated in sectors and geographies like US healthcare where we underperformed. Advisory revenues were flat versus the prior year at €137 million, but 12% higher than the third quarter. The revenue performance in A&O in the fourth quarter doesn't yet fully reflect the momentum we see building in the business from accelerating client engagement and growing pipelines. In M&A, we were third in global announced transactions in the fourth quarter and continue to see our pipeline build. The pipeline is also higher in DCM and the quality of our equity pipeline has improved with higher ratings towards IPOs than was the case a year ago. Which we believe is a further indicator of the recovery in this business. So as we enter 2018, we are very confident that our efforts to build our corporate finance business will continue to bear fruit. Let me turn to financing, fixed income and currencies and equities on Page 12. Starting with financing which reported a 16% decline in the fourth quarter revenues to €522 million from a strong prior year quarter. The decline resulted from lower revenues in commercial real estate and asset-backed lending, investment grade and the impact of higher funding charges. Turning to fixed sales and trading. Fourth quarter revenues reported of €554 million represented a 29% decline year-over-year. Including the FIC related parts of our financing segment to facilitate a more accurate peer comparison. Year-over-year quarterly FIC sales and trading revenues declined by 20%. As was the case for much of 2017, the market environment for fixed income remain challenged with low volatility across all major asset classes and subdued client activity in key business combined with unfavorable FX movements and increased liquidity related funding costs. Additionally, challenging trading conditions in some areas like emerging markets further contributed to the weak quarterly results. Let me briefly review each of the major businesses in FIC. Credit performed well as revenues were broadly fat compared to a good fourth quarter of 2016. Revenues and rates were significantly higher albeit versus a challenging fourth quarter of 2016 and with particular strength in Europe. Foreign exchange declined significantly as both volatility and client flows were lower compared to the fourth quarter of 2016 that benefited from an active trading environment especially around the US Presidential Elections. Emerging markets results in the quarter were particularly weak driven by subdued client activity levels but more significantly difficult trading conditions in a number of markets like Venezuela, South Africa and Turkey. Equity sales and trading quarterly revenues declined 25% to €332 million reflecting significantly lower revenues in equity derivatives largely due to adverse market conditions that caused poor trading results particularly in European derivatives and lower cash equities revenues largely from reduced market volumes in both Europe and the Americas. However, Prime Finance revenues increased year-over-year reflecting continued growth in balances and improved margins. Overall we believe that our Prime Finance business enters 2018 in a much stronger position. Our average Prime Finance balances are now above the levels of late 2016, with stable margins versus the third quarter 2017 and materially higher than 12 months ago. Let me now review the private and commercial bank starting on Page 13. For the full year we reported PCB EBIT of €382 million, a 73% decline from 2016 and revenues of €10.2 billion, 8% lower year-on-year. Revenues were affected by number of non-operational items that included the positive impact from Hua Xia and the US PCS business in 2016. And a contra revenue impact resulting from the agreed partial sale of our Polish retail business in the fourth quarter of 2017. Excluding the impact of these non-operational items which we disclosed on this slide. 2017 PCB revenues were flat year-over-year as higher fee income and loan growth offset the impact from persistently low interest rates on deposit revenues. For the full year 2017 noninterest expenses increased 3% to €9.5 billion largely driven by higher restructuring costs. Adjusted costs for 2017 of €9 billion were essentially flat to the prior year as cost saves from measures like branch closures and the absence of expenses related to PCS were offset by ongoing investment spending particularly in technology and higher variable compensation. In the fourth quarter, PCB reported an EBIT loss of €659 million on quarterly revenues of €2.3 billion. Excluding the impact of the non-operational items PCB revenues in the quarter were flat as higher loan revenues offset lower deposit revenues. Fourth quarter noninterest expenses increased 22% to €2.9 billion driven by €400 million of restructuring expense and higher adjusted costs. Adjusted cost of €2.4 billion in the fourth quarter grew 7% versus the prior year period as realized cost savings during 2017 were offset by increased investment spending and higher variable compensation. Let me now turn to the individual businesses within PCB on Page 14. Fourth quarter revenues in private and commercial clients of €1.1 billion declined 14% largely due to the €160 million contra revenue for the Poland transaction. Excluding this impact operational revenues in PCC were essentially flat in the fourth quarter. Fourth quarter revenues in Postbank of €802 million were down 3% versus the prior year period primarily from one-off gains. Excluding these gains revenues were essentially flat as loan growth and higher fee income from current accounts offset continued margin pressure in deposit revenues. Wealth management revenues in the fourth quarter €452 million increased 14% versus the prior year period largely from gains related to the workout of Sal. Oppenheim. Portfolios and asset sale. Let me end the PCB discussion with the observation that deposit revenues will remain under pressure throughout 2018. That we expect to offset that largely with growth in loans and fee income, as is been the case for most of 2017. Let me now turn to asset management on Page 15. When looking at asset management's year-over-year comparisons you need to keep in mind that last year included Abbey Life in our operations, which affected asset management's results by a gross up of revenues which was then offset by an expense item for policyholder benefits and claims. Additionally, there were also core Abbey revenues not included in the gross up and in the fourth quarter of 2016, a €1 billion impairment related to the disposal of Abbey. To better see the operational performance of asset management, we disclosed the revenue and EBIT impact on Abbey on the slide. We've also included a more detail reconciliation to get from our reported asset management results here to standalone, proforma, DWS results on Page 27 in the appendix. 2017 reported EBIT was €725 million versus €206 million loss in 2016, a decline less than 1% excluding Abbey. Reported 2017 revenues declined 16% to €2.5 billion, but excluding Abbey grew 2% year-over-year largely driven by higher management fees. Fourth quarter asset management EBIT over €115 million fell 45% year-over-year excluding Abbey. Largely reflecting the 2% decline in revenues driven by primarily by lower periodic performance fees in alternatives and active and higher adjusted costs. Ex-Abbey, noninterest expenses in the fourth quarter rose 20%, as the prior year period included one-off provision release. While in the full year noninterest expenses were 3% higher. Assets under management were €702 billion at year end, a €4 billion decline versus 2016. As €16 billion of net new inflows were offset by FX and the impact of disposals primarily from the US private equity business and the Luxemburg based Sal. Oppenheim. Asset servicing business. Turning briefly to C&A on Page 16. C&A was in EBIT loss of €67 million in the fourth quarter and €695 million for 2017. Most of the year-on-year quarterly decline reflected valuation and timing differences trigged by changes in the bank's credit spreads while the full year also included previously disclosed negative currency translation adjustment related to the sale of our operations in Argentina and Uruguay. Let me conclude with some brief outlook remarks. Our original adjusted cost target for 2018 was €22 billion of that included approximately €900 million of planned cost savings that we highlighted last March would be achieved through business disposals, while we made progress on planned disposals many of which we've announced plans for some those sales have been delayed and in some cases suspended. As a result, we currently do not expect the planned €900 million of cost savings to materialize in 2018. Nonetheless, based on transactions that have either being signed or expected to sign and close within the year approximately €300 million of the cost savings from these business sales would impact our 2019 results. In the interim we will continue our efforts to complete more of these business sales. We do expect the approximately €900 million on cost associated with these business will be a bit neutral to slightly positive in 2018 as we also retain the associated revenues. We also had unplanned cost items arise in the 2018 planning process from items like higher than expected BREXIT costs and Method II [ph] impacts. Additionally some of the cost synergies originally plan to materialize in 2018 from the merger of Postbank into our German banking entity have been delayed, as we now expect to complete that merger in the second quarter. As a result those savings are now expected to be realized in 2019. Nonetheless, we've been taking additional measures to offset these and other impacts and also expect to benefit from current FX rates in our reported costs relative to our earlier planning assumptions. So putting that all together, we now expect our adjusted cost in 2018 will be approximately €23 billion which reflects our original €22 billion target plus the cost impact of the delayed and suspended business sales. In terms of the outlook for credit; provisions in 2017 were lower than we'd anticipated and were unusually low by historic standards. But these results did benefit from a number of recoveries that are unlikely to repeat. So we expect to see increases in credit costs in 2018 that would suggest that full year credit provisions will likely be closer to historically normal levels for us rather than the €500 million recorded in 2017. In addition let me remind you, that with the implementation of IFRS 9, hence forth credit costs will be more sensitive than in the past to changes in the credit outlook. In terms of restructuring we're very focused on achieving our cost saving while delivering restructuring expense below current guidance overtime, but currently we expect restructuring expense in 2018 to be broadly in line with 2017 levels. Litigation expense in 2017 was unexpectedly low given the success we had in resolving a number of matters below our estimated provisions, but while still building additional provisions throughout the year. But as we look into 2018 and with the caveat forecasting litigation expense is difficult to do with precision. We would expect litigation to be meaningfully higher than 2017, well below the elevated level seen over the past number of years. That said, overtime we expect that litigation will continue to decrease reflecting not only the resolution of legacy matters, but also the impact of our multiyear investments in our control and compliance functions. Turning to the broader economic, our outlook. We're optimistic about 2018 as John noted. The global economic backdrop is clearly strengthening and that is driving acceleration of client engagement and expectations of eventual interest rates normalization in the Eurozone bode well for our future revenues given the interest rate sensitivity of our balance sheet. To echo John's previous comments notwithstanding the current prospects of an improvement in the operating environment we will continue to manage our risk levels and balance sheet conservatively. Permit me a final comment before turning to your questions. Which is that we must attack our costs with renewed vigor. Deutsche Bank has long been justly criticized for being a core cost manager and we're not happy with our fourth quarter performance. That said, we're slowly turning this ship around if you look at our adjusted cost trends, these past two years. the revenue weakness of the last year underscore that we're not cutting fast enough and also challenging in our goal of achieving positive operating leverage [ph]. So we're going to be even more aggressive on cost management. Deutsche Bank's cost culture simply has to improve and John and I have made that a priority in 2018. With that, John and I will be now happy to take your questions.